Merck application for Keytruda plus chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma accepted by USFDA for priority review Ruchika Sharma22 Feb 2024 12:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...
GSK Gets CDSCO Panel Nod to study safety of anti-cancer drug Dostarlimab Dr. Divya Colin23 Dec 2023 6:00 PM ISTNew Delhi: Citing that the total number of evaluable patients in the study should be a minimum of 30, the Subject Expert Committee (SEC) functional...
Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma20 Dec 2023 2:30 PM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
GSK gets European Commission marketing authorisation for Jemperli, chemotherapy combo for endometrial cancer Ruchika Sharma13 Dec 2023 3:30 PM ISTLondon: GSK plc has announced the European Commission (EC) has granted marketing authorisation for Jemperli (dostarlimab) in combination with...
Night Shift Work Not Fully Linked to Endometrial Cancer in Postmenopausal Women Jacinthlyn Sylvia7 Nov 2023 9:00 PM ISTA recent study by the Epidemiology of Endometrial Cancer Consortium (E2C2) suggests that there is limited evidence to support night shift work and...
Phase III trial of Jemperli plus chemotherapy meets endpoint of overall survival in patients with primary advanced or recurrent endometrial cancer: GSK Ruchika Sharma31 Oct 2023 11:35 AM ISTLondon: GSK plc has announced positive headline results from a planned analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...
GSK gets positive EMA Committee opinion recommending approval of Jemperli plus chemotherapy for endometrial cancer Ruchika Sharma19 Oct 2023 2:41 PM ISTUK: GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive...
Metformin effective adjunct to lifestyle modification among women with PCOS Niveditha Subramani24 Aug 2023 10:00 AM ISTMetformin is most commonly prescribed oral insulin sensitising agents. In the past two decades, its properties as an insulin sensitising agent have...
GSK gets USFDA nod for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer Ruchika Sharma1 Aug 2023 11:30 AM ISTJemperli is already approved in the US as monotherapy in adult patients with dMMR recurrent or advanced endometrial cancer that has progressed on or...
GSK supplemental application for Jemperli plus chemotherapy accepted by USFDA for endometrial cancer Ruchika Sharma6 Jun 2023 3:28 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
GSK gets CDSCO Panel nod to import, market anticancer drug Dostarlimab Susmita Roy14 March 2023 6:00 PM ISTNew Delhi: Highlighting the unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
UK study shows increased cancer mortality in people with type 2 diabetes Dr. Kamal Kant Kohli29 Jan 2023 8:00 PM ISTNew research, funded by Hope Against Cancer and published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD])...
